Metrics in Balance NV
Metrics in Balance N.V. owns and operates healthcare clinics in the Netherlands. The company offers chiropractic care and physical therapy, lifestyle testing, and occluso-posture therapy services. Metrics in Balance N.V. was incorporated in 2016 and is based in Gent, Belgium.
Metrics in Balance NV (MLMIB) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, Metrics in Balance NV (MLMIB) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 0.22 |
Metrics in Balance NV - Net Assets Trend (2017–2022)
This chart illustrates how Metrics in Balance NV's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Metrics in Balance NV (2017–2022)
The table below shows the annual net assets of Metrics in Balance NV from 2017 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | €11.75 Million | -0.45% |
| 2021-12-31 | €11.80 Million | +0.02% |
| 2020-12-31 | €11.80 Million | +0.01% |
| 2019-12-31 | €11.80 Million | +3280.61% |
| 2018-12-31 | €-370.92K | -117.86% |
| 2017-12-31 | €-170.25K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Metrics in Balance NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 45865100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €12.44 Million | 105.88% |
| Other Components | €1.00 | 0.00% |
| Total Equity | €11.75 Million | 100.00% |
Metrics in Balance NV Competitors by Market Cap
The table below lists competitors of Metrics in Balance NV ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Standard Bank Group Ltd. 6.5% Pfd.
JSE:SBKP
|
$312.12 |
|
CIPUTRA DEVT
MU:PUWA
|
$312.28 |
|
Innovative Holdings Alliance Inc
PINK:IHAI
|
$312.43 |
|
Tri-Star Power Ltd
KAR:TSPL
|
$312.79 |
|
Victorias Milling Company Inc
PSE:VMC
|
$311.41 |
|
Pace Pakistan Ltd
KAR:PACE
|
$311.33 |
|
REC SILICON (R3Q.SG)
STU:R3Q
|
$311.16 |
|
TPL Reit Fund 1
KAR:TPLRF1
|
$310.84 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Metrics in Balance NV's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 11,801,054 to 11,747,595, a change of -53,459 (-0.5%).
- Net loss of 53,459 reduced equity.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-53.46K | -0.46% |
| Total Change | €- | -0.45% |
Book Value vs Market Value Analysis
This analysis compares Metrics in Balance NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €-0.08 | €0.03 | x |
| 2018-12-31 | €-0.18 | €0.03 | x |
| 2019-12-31 | €2.69 | €0.03 | x |
| 2020-12-31 | €2.69 | €0.03 | x |
| 2021-12-31 | €2.69 | €0.03 | x |
| 2022-12-31 | €2.68 | €0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Metrics in Balance NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.46%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -17819.67%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.07x
- Recent ROE (-0.46%) is below the historical average (-0.22%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | -412.78% | 0.72x | 0.00x | €-214.73K |
| 2018 | 0.00% | -22288.14% | 0.02x | 0.00x | €-263.57K |
| 2019 | -0.92% | -329.97% | 0.00x | 1.04x | €-1.29 Million |
| 2020 | 0.01% | 2.11% | 0.00x | 1.04x | €-1.18 Million |
| 2021 | 0.02% | 4.71% | 0.00x | 1.05x | €-1.18 Million |
| 2022 | -0.46% | -17819.67% | 0.00x | 1.07x | €-1.23 Million |
Industry Comparison
This section compares Metrics in Balance NV's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $53,089,500
- Average return on equity (ROE) among peers: -8.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Metrics in Balance NV (MLMIB) | €- | 0.00% | N/A | $311.84 |
| Euromedis Groupe SA (ALEMG) | $34.88 Million | -17.07% | 0.72x | $4.87 Million |
| Bastide Le Confort Médical SA (BLC) | $71.30 Million | 0.74% | 8.27x | $81.11 Million |